Universal Ibogaine Inc.
IBOGF · OTC
4/30/2025 | 1/31/2025 | 4/30/2023 | 1/31/2023 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 88.6% | -13.2% | 937.9% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | 3.1% | 100% | 100% |
| EBITDA | $0 | -$0 | -$0 | -$0 |
| % Margin | 7.5% | -44.6% | -80.9% | -1,784.8% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -9.4% | -81.9% | -113.6% | -1,921.3% |
| EPS Diluted | -0 | -0.001 | -0.003 | -0.004 |
| % Growth | 80% | 60% | 39% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |